Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125732432 | 12573243 | 2 | F | 20160713 | 20160720 | 20160728 | EXP | JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-120060 | RANBAXY | 60.00 | YR | M | Y | 0.00000 | 20160728 | OT | GB | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125732432 | 12573243 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 400 MG, DAILY (200 MG IN THE MORNING AND 200 MG IN THE LATE AFTERNOON) INITIAL DOSE WAS 200 MG | Y | Y | 76606 | 400 | MG | ||||||
| 125732432 | 12573243 | 2 | I | VALPROIC ACID. | VALPROIC ACID | 1 | Oral | 1200 MG, DAILY | U | U | 0 | 1200 | MG | ||||||
| 125732432 | 12573243 | 3 | I | Flunitrazepam | FLUNITRAZEPAM | 1 | Oral | BEFORE BEDTIME | U | U | 0 | ||||||||
| 125732432 | 12573243 | 4 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 200 MG (100 MG IN THE MORNING AND 100 MG LATE AFTERNOON) | U | U | 0 | 200 | MG | ||||||
| 125732432 | 12573243 | 5 | C | Loxoprofen | LOXOPROFEN | 1 | Oral | 180 MG, UNK | U | U | 0 | 180 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125732432 | 12573243 | 1 | Neuralgia |
| 125732432 | 12573243 | 2 | Epilepsy |
| 125732432 | 12573243 | 3 | Insomnia |
| 125732432 | 12573243 | 4 | Neuralgia |
| 125732432 | 12573243 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125732432 | 12573243 | OT |
| 125732432 | 12573243 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125732432 | 12573243 | Drug interaction | |
| 125732432 | 12573243 | Gait disturbance | Gait disturbance |
| 125732432 | 12573243 | Muscular weakness | Muscular weakness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |